52North
52North is a healthcare company in Cambridge, United Kingdom, founded in 2018. It has 1 recorded funding round, most recently a Venture Round in December 2024.
Transforming emergency care
- Headquarters
- Cambridge
- Founded
- 2018
- Website
- 52north.health
- Last Round
- Venture RoundDec 2024
- Rounds
- 1
Indexed holds 1 funding round for this company. The full record is or through the API.
About
52North develops diagnostic and digital solutions with patients and clinicians to make emergency care safer and more effective. Its Neutrocheck product combines a portable finger-prick blood test and app to help identify immunosuppressed patients at risk of neutropenic sepsis. Its ACORN digital tool supports remote triaging and management of emergency cancer care needs. The website states that these products remain in development and are not available for sale.
Summary
Its most recent funding was a Venture Round in Dec 2024.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2024
Similar Companies
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
China's leading blood products manufacturer
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/52north"><img src="https://indexed.vc/api/badge/company/52north" alt="52North on Indexed.vc" width="260" height="76" /></a>
